參考文獻 |
[1] Shegokar R, Sawant S. Cancer research and therapy: Where are we today?. International Journal of Cancer Therapy and Oncology. 2014 October 2(4): 02048. doi: 10.14319/ijcto.0204.8
[2] IARC Press release, 2013. Available from http://ci5.iarc.fr/ [Accessed on May 02, 2014]
[3] Mithoowani H, Febbraro M. Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology. Curr Oncol. 2022 Mar 9;29(3):1828-1839. doi: 10.3390/curroncol29030150. PMID: 35323350; PMCID: PMC8946954.
[4] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
[4] Luo YH, Chiu CH, Scott Kuo CH, Chou TY, Yeh YC, Hsu HS, Yen SH, Wu YH, Yang JC, Liao BC, Hsia TC, Chen YM. Lung Cancer in Republic of China. J Thorac Oncol. 2021 Apr;16(4):519-527. doi: 10.1016/j.jtho.2020.10.155. PMID: 33781442.
[5] Chang YJ, Huang JY, Lin CH, Wang BY. Survival and Treatment of Lung Cancer in Taiwan between 2010 and 2016. J Clin Med. 2021 Oct 12;10(20):4675. doi: 10.3390/jcm10204675. PMID: 34682798; PMCID: PMC8540538.
[6] Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I, Wichmann HE, Merletti F, Richiardi L, Simonato L, Fortes C, Siemiatycki J, Parent ME, Consonni D, Landi MT, Caporaso N, Zaridze D, Cassidy A, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, Stücker I, Fabianova E, Dumitru RS, Bencko V, Foretova L, Janout V, Rudin CM, Brennan P, Boffetta P, Straif K, Brüning T. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012 Sep 1;131(5):1210-9. doi: 10.1002/ijc.27339. Epub 2011 Dec 14. PMID: 22052329; PMCID: PMC3296911.
[7] Dubin S, Griffin D. Lung Cancer in Non-Smokers. Mo Med. 2020 Jul-Aug;117(4):375-379. PMID: 32848276; PMCID: PMC7431055.
[8] Riudavets M, Garcia de Herreros M, Besse B, Mezquita L. Radon and Lung Cancer: Current Trends and Future Perspectives. Cancers (Basel). 2022 Jun 27;14(13):3142. doi: 10.3390/cancers14133142. PMID: 35804914; PMCID: PMC9264880.
[9] Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0. PMID: 33446664; PMCID: PMC8177722.
[10] Basumallik N, Agarwal M. Small Cell Lung Cancer. [Updated 2022 Jul 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482458/
[11] Raz DJ, Gomez SL, Chang ET, Kim JY, Keegan TH, Pham J, Kukreja J, Hiatt RA, Jablons DM. Epidemiology of non-small cell lung cancer in Asian Americans: incidence patterns among six subgroups by nativity. J Thorac Oncol. 2008 Dec;3(12):1391-7. doi: 10.1097/JTO.0b013e31818ddff7. PMID: 19057262; PMCID: PMC5737739.
[12] Kim J, Lee H, Huang BW. Lung Cancer: Diagnosis, Treatment Principles, and Screening. Am Fam Physician. 2022 May 1;105(5):487-494. PMID: 35559635.
[13] Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011 Dec;32(4):605-44. doi: 10.1016/j.ccm.2011.09.001. PMID: 22054876; PMCID: PMC3864624.
[14] Zappa C, Mousa SA. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016 Jun;5(3):288-300. doi: 10.21037/tlcr.2016.06.07. PMID: 27413711; PMCID: PMC4931124.
[15] Glatzer M, Schmid S, Radovic M, Früh M, Putora PM. The role of radiation therapy in the management of small cell lung cancer. Breathe (Sheff). 2017 Dec;13(4):e87-e94. doi: 10.1183/20734735.009617. PMID: 29928456; PMCID: PMC6003267.
[16] Amjad MT, Chidharla A, Kasi A. Cancer Chemotherapy. [Updated 2023 Feb 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK564367/
[17] Shrestha A, Martin C, Burton M, Walters S, Collins K, Wyld L. Quality of life versus length of life considerations in cancer patients: A systematic literature review. Psychooncology. 2019 Jul;28(7):1367-1380. doi: 10.1002/pon.5054. Epub 2019 May 15. PMID: 30838697; PMCID: PMC6619389.
[18] Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18(1-2):43-73. doi: 10.1615/critrevoncog.v18.i1-2.40. PMID: 23237552; PMCID: PMC3597235.
[19] Leong SP, Naxerova K, Keller L, Pantel K, Witte M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin Exp Metastasis. 2022 Feb;39(1):159-179. doi: 10.1007/s10585-021-10120-z. Epub 2021 Nov 12. PMID: 34767139; PMCID: PMC8967809.
[20] Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002 Aug;2(8):563-72. doi: 10.1038/nrc865. PMID: 12154349.
[21] Park HK, Han J, Kwon GY, Yeo MK, Bae GE. Patterns of Extrathoracic Metastasis in Lung Cancer Patients. Curr Oncol. 2022 Nov 16;29(11):8794-8801. doi: 10.3390/curroncol29110691. PMID: 36421344; PMCID: PMC9689009.
[22] Marshall AC. Traditional Chinese Medicine and Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. 2020 Mar 2:455–82. doi: 10.1007/978-3-319-68864-0_60. PMCID: PMC7356495.
[23] Wang L, Zhou GB, Liu P, Song JH, Liang Y, Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, Chen SJ, Chen Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4826-31. doi: 10.1073/pnas.0712365105. Epub 2008 Mar 14. PMID: 18344322; PMCID: PMC2290784.
[24] Xiang ML, Hu BY, Qi ZH, Wang XN, Xie TZ, Wang ZJ, Ma DY, Zeng Q, Luo XD. Chemistry and bioactivities of natural steroidal alkaloids. Nat Prod Bioprospect. 2022 Jun 15;12(1):23. doi: 10.1007/s13659-022-00345-0. PMID: 35701630; PMCID: PMC9198197.
[25] Shen KH, Hung JH, Chang CW, Weng YT, Wu MJ, Chen PS. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression. Chem Biol Interact. 2017 Apr 25;268:129-135. doi: 10.1016/j.cbi.2017.03.005. Epub 2017 Mar 7. PMID: 28283413.
[26] Bayat A. Science, medicine, and the future: Bioinformatics. BMJ. 2002 Apr 27;324(7344):1018-22. doi: 10.1136/bmj.324.7344.1018. PMID: 11976246; PMCID: PMC1122955.
[27] Trevino V, Falciani F, Barrera-Saldaña HA. DNA microarrays: a powerful genomic tool for biomedical and clinical research. Mol Med. 2007 Sep-Oct;13(9-10):527-41. doi: 10.2119/2006-00107.Trevino. PMID: 17660860; PMCID: PMC1933257.
[28] Govindarajan R, Duraiyan J, Kaliyappan K, Palanisamy M. Microarray and its applications. J Pharm Bioallied Sci. 2012 Aug;4(Suppl 2):S310-2. doi: 10.4103/0975-7406.100283. PMID: 23066278; PMCID: PMC3467903.
[29] Li X, Gu W, Mohan S, Baylink DJ. DNA microarrays: their use and misuse. Microcirculation. 2002 Jan;9(1):13-22. doi: 10.1038/sj.mn.7800118. PMID: 11896556.
[30] Tarca AL, Romero R, Draghici S. Analysis of microarray experiments of gene expression profiling. Am J Obstet Gynecol. 2006 Aug;195(2):373-88. doi: 10.1016/j.ajog.2006.07.001. PMID: 16890548; PMCID: PMC2435252.
[31] Heller MJ. DNA microarray technology: devices, systems, and applications. Annu Rev Biomed Eng. 2002;4:129-53. doi: 10.1146/annurev.bioeng.4.020702.153438. Epub 2002 Mar 22. PMID: 12117754.
[32] Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006 Sep 29;313(5795):1929-35. doi: 10.1126/science.1132939. PMID: 17008526.
[33] Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, Lahr DL, Hirschman JE, Liu Z, Donahue M, Julian B, Khan M, Wadden D, Smith IC, Lam D, Liberzon A, Toder C, Bagul M, Orzechowski M, Enache OM, Piccioni F, Johnson SA, Lyons NJ, Berger AH, Shamji AF, Brooks AN, Vrcic A, Flynn C, Rosains J, Takeda DY, Hu R, Davison D, Lamb J, Ardlie K, Hogstrom L, Greenside P, Gray NS, Clemons PA, Silver S, Wu X, Zhao WN, Read-Button W, Wu X, Haggarty SJ, Ronco LV, Boehm JS, Schreiber SL, Doench JG, Bittker JA, Root DE, Wong B, Golub TR. A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles. Cell. 2017 Nov 30;171(6):1437-1452.e17. doi: 10.1016/j.cell.2017.10.049. PMID: 29195078; PMCID: PMC5990023.
[34] Mousavi SZ, Rahmanian M, Sami A. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection. Infect Genet Evol. 2020 Dec;86:104610. doi: 10.1016/j.meegid.2020.104610. Epub 2020 Oct 29. PMID: 33130005; PMCID: PMC7598903.
[35] Musa A, Ghoraie LS, Zhang SD, Glazko G, Yli-Harja O, Dehmer M, Haibe-Kains B, Emmert-Streib F. A review of connectivity map and computational approaches in pharmacogenomics. Brief Bioinform. 2018 May 1;19(3):506-523. doi: 10.1093/bib/bbw112. Erratum in: Brief Bioinform. 2017 Sep 1;18(5):903. PMID: 28069634; PMCID: PMC5952941.
[36] Wu D, Pepowski B, Takahashi S, Kron SJ. A cMap-enabled gene expression signature-matching approach identifies small-molecule inducers of accelerated cell senescence. BMC Genomics. 2019 Apr 15;20(1):290. doi: 10.1186/s12864-019-5653-x. PMID: 30987592; PMCID: PMC6466706.
[37] Iwata M, Yamanishi Y. The Use of Large-Scale Chemically-Induced Transcriptome Data Acquired from LINCS to Study Small Molecules. Methods Mol Biol. 2019;1888:189-203. doi: 10.1007/978-1-4939-8891-4_11. PMID: 30519948.
[38] Sever R, Brugge JS. Signal transduction in cancer. Cold Spring Harb Perspect Med. 2015 Apr 1;5(4):a006098. doi: 10.1101/cshperspect.a006098. PMID: 25833940; PMCID: PMC4382731.
[39] Gilbert SF. Developmental Biology. 6th edition. Sunderland (MA): Sinauer Associates; 2000. Cell Surface Receptors and Their Signal Transduction Pathways. Available from: https://www.ncbi.nlm.nih.gov/books/NBK10043/
[40] Liu T, Zhang L, Joo D, Sun SC. NF-κB signalling in inflammation. Signal Transduct Target Ther. 2017;2:17023–. doi: 10.1038/sigtrans.2017.23. Epub 2017 Jul 14. PMID: 29158945; PMCID: PMC5661633.
[41] Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-κB signalling in inflammation and cancer. MedComm (2020). 2021 Dec 16;2(4):618-653. doi: 10.1002/mco2.104. PMID: 34977871; PMCID: PMC8706767.
[42] Xia Y, Shen S, Verma IM. NF-κB, an active player in human cancers. Cancer Immunol Res. 2014 Sep;2(9):823-30. doi: 10.1158/2326-6066.CIR-14-0112. PMID: 25187272; PMCID: PMC4155602.
[43] Hayden MS, Ghosh S. Signalling to NF-kappaB. Genes Dev. 2004 Sep 15;18(18):2195-224. doi: 10.1101/gad.1228704. PMID: 15371334.
[44] Fuentes N, Silveyra P. Estrogen receptor signalling mechanisms. Adv Protein Chem Struct Biol. 2019;116:135-170. doi: 10.1016/bs.apcsb.2019.01.001. Epub 2019 Feb 4. PMID: 31036290; PMCID: PMC6533072.
[45] Li Y, Wang JP, Santen RJ, Kim TH, Park H, Fan P, Yue W. Estrogen stimulation of cell migration involves multiple signalling pathway interactions. Endocrinology. 2010 Nov;151(11):5146-56. doi: 10.1210/en.2009-1506. Epub 2010 Sep 22. PMID: 20861240; PMCID: PMC2954727.
[46] Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol. 2004 Feb;6(2):154-61. doi: 10.1038/ncb1094. Epub 2004 Jan 25. PMID: 14743221.
[47] Singleton PA, Bourguignon LY. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signalling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp Cell Res. 2004 Apr 15;295(1):102-18. doi: 10.1016/j.yexcr.2003.12.025. PMID: 15051494.
[48] Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018 May 10;11(1):64. doi: 10.1186/s13045-018-0605-5. PMID: 29747682; PMCID: PMC5946470.
[49] Wang YY, Vadhan A, Chen PH, Lee YL, Chao CY, Cheng KH, Chang YC, Hu SC, Yuan SF. CD44 Promotes Lung Cancer Cell Metastasis through ERK-ZEB1 Signalling. Cancers (Basel). 2021 Aug 12;13(16):4057. doi: 10.3390/cancers13164057. PMID: 34439211; PMCID: PMC8392539.
[50] Zhao L, Huang S, Mei S, Yang Z, Xu L, Zhou N, Yang Q, Shen Q, Wang W, Le X, Lau WB, Lau B, Wang X, Yi T, Zhao X, Wei Y, Warner M, Gustafsson JÅ, Zhou S. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis. Proc Natl Acad Sci U S A. 2018 Apr 17;115(16):E3673-E3681. doi: 10.1073/pnas.1803291115. Epub 2018 Mar 28. PMID: 29592953; PMCID: PMC5910874 |